<DOC>
	<DOCNO>NCT00996801</DOCNO>
	<brief_summary>This study seek demonstrate additional gain bone mineral density ( BMD ) achieve switch MK-5442 oral bisphosphonate participant receive oral bisphosphonate therapy least 3 year .</brief_summary>
	<brief_title>MK-5442 Treatment Osteoporosis Postmenopausal Women Previously Treated With Oral Bisphosphonate ( MK-5442-012 )</brief_title>
	<detailed_description>The study originally plan duration 2 year include efficacy analysis 15 mg MK-5442 treatment arm . Amendment 1 protocol eliminate 2nd year study well 15-mg arm . Enrollment 15-mg MK-5442 arm stop result amendment participant randomly assign MK-5442 15-mg treatment arm discontinue study .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>Taking oral bisphosphonate treatment osteoporosis least 3 past 4 year . At present , past 12 month , treat alendronate Bone Mineral Density ( BMD ) Tscore ≤ 1.5 one follow anatomic site ; lumbar spine , femoral neck , trochanter , total hip , AND BMD Tscore sit ≥ 4.0 , AND history least one fragility fracture , OR , BMD Tscore ≤ 2.5 one follow anatomic site ; lumbar spine , femoral neck , trochanter , total hip , AND BMD Tscore sit ≥ 4.0 Postmenopausal least 5 year Obesity ( ie , weight great 250 pound ) prohibits use dualemission Xray absorptiometry ( DXA ) Received intravenous ( IV ) bisphosphonates , fluoride treatment dose &gt; 1 mg/day 2 week , strontium , growth hormone , cathepsin K ( CTSK ) inhibitor , receptor activator nuclear factor kappaB ligand ( RANKL ) inhibitor time past Use oral bisphosphonates alendronate last 12 month , parathyroid hormone ( PTH ) last 24 month , cyclosporin 2 week last 6 month , heparin last 2 week , anabolic steroid glucocorticoid 2 week past 6 month Use estrogen without progestin selective estrogen receptor modulator ( SERM ) last 6 month calcitonin last 30 day Has use pioglitazone hydrochloride rosiglitazone hydrochloride last 6 month Taking 10,000 International Units ( IU ) vitamin A daily 5,000 IU vitamin D daily Has total thyroidectomy History Paget 's disease Has human immunodeficiency virus ( HIV ) History cancer last 5 year , except certain skin cervical cancer History major upper gastrointestinal ( GI ) mucosal erosive disease Unable adhere dose instruction alendronate regard fast position Not ambulatory</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>